NTLA Competitors & Alternatives
Compare Intellia Therapeutics Inc with similar stocks in the same industry
Biotechnology
NTLA
Main Stock$11.65
Tradestie Score
58
Market Cap
$2.01B
Revenue Growth
-0.5%
Analyst Upside
+98.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corporation Common Stock
|
$149.13
|
$1.77B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$23.01
|
$1.74B | - | 50 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$29.37
|
$1.68B | - | 61 | Compare |
|
MNKD
Mannkind Corporation
|
$3.05
|
$1.65B | - | 57 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.65
|
$1.63B | - | 60 | Compare |
|
BHVN
Biohaven Ltd.
|
$11.75
|
$1.57B | - | 67 | Compare |
|
VCEL
Vericel Corporation
|
$40.94
|
$1.56B | 86.3 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$78.10
|
$1.55B | - | 59 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$38.31
|
$1.55B | 12.5 | 67 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$30.66
|
$1.55B | - | 62 | Compare |
More NTLA Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2835)
221 stocks in this industry